Chemical company Platform to buy Arysta LifeScience for $3.5 bln
October 20, 2014 at 07:35 AM EDT
Oct 20 (Reuters) - Specialty chemicals company Platform Specialty Products Corp said it will buy rival Arysta LifeScience Ltd from a company backed by private equity firm Permira for about $3.51 billion.
